Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2023-12-01
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prehabilitation in Esophageal Cancer Care
NCT04581005
Prehabilitation in Patients With Esophageal or Gastric Cancers
NCT03418298
Patient-centered REhabilitation Program to Advance REcovery
NCT07189000
The PREPARE for Cancer Surgery Study
NCT06503185
Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program
NCT03865875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research study procedures include screening for eligibility, clinic visits, questionnaires, blood tests, and Computed Tomography (CT) scans.
Participation in this research study is expected to last 7 months.
It is expected about 30 patients will participate in this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prehabilitation Program
30 participants will be enrolled and will complete study procedures as follows:
* Enrollment at least 4 weeks prior to esophageal cancer surgery.
* In-person clinic visit with dietitian and physical therapist for assessments, and completion of baseline questionnaires with study coordinator.
* Adherence to daily physical function, dietary, and sleep recommendations and consumption of 5-day immunonutrition supplement.
* Regular electronic/phone-call check-ins with study staff.
* Telehealth appointment with physical therapist and dietitian prior to surgery.
* After surgery and during hospital admission, final visit with dietitian and physical therapist for assessments, and completion of questionnaires.
* 6-month follow-up period.
Prehabilitation Program
Multimodal prehabilitation program consisting of pre-surgical optimization of nutrition, physical function, and sleep health via individualized plans. Participants will also be supplied with Nestle Impact Advances Recovery Immunonutrition Drink.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prehabilitation Program
Multimodal prehabilitation program consisting of pre-surgical optimization of nutrition, physical function, and sleep health via individualized plans. Participants will also be supplied with Nestle Impact Advances Recovery Immunonutrition Drink.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult male or non-pregnant female volunteers
* Completed neoadjuvant chemotherapy or radiotherapy for esophageal cancer
* At least four weeks to esophageal cancer surgery
* Without skin conditions that preclude wearing sensors
* Able to speak English and consent
Exclusion Criteria
* Dietary restrictions that prevent consumption of nutritional supplements
* Women who are pregnant, nursing, or at risk of becoming pregnant
* Profound physical disability (for example, quadriplegia) that precludes participation in any aerobic or strength training.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hassan Dashti
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hassan Dashti, PhD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-085
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.